# Ethanol lock therapy for salvage of infected tunnelled haemodialysis catheters: a randomised controlled trial

**Authors:** Hari Prasad M K, Lalit K Pursnani, Himansu Sekhar Mahapatra, Muthukumar Balkrishnan, Renju Binoy, Vipin Dev, Varuna Yadav, Disha Arora

PMC · DOI: 10.1093/ckj/sfag013 · Clinical Kidney Journal · 2026-01-19

## TL;DR

Using ethanol lock therapy alongside antibiotics improves catheter salvage and reduces infection recurrence in hemodialysis patients.

## Contribution

This study provides robust evidence that ethanol lock therapy is effective for salvaging infected hemodialysis catheters.

## Key findings

- Ethanol lock therapy improved early catheter salvage rates compared to antibiotics alone.
- ELT significantly reduced infection recurrence at 60 days.
- Fever resolution was more common in patients receiving ethanol lock therapy.

## Abstract

Tunnelled catheter–related bloodstream infections (CRBSIs) in haemodialysis (HD) are challenging to manage due to biofilm formation. Ethanol lock therapy (ELT) has demonstrated potential as an adjunct to antibiotics for catheter salvage, but robust evidence is limited.

We conducted a single-centre, open-label, randomised controlled trial of adult HD patients with suspected or confirmed CRBSI. Patients received either 70% ELT plus intravenous antibiotics or intravenous antibiotics alone. Primary outcome was catheter salvage at day 7. Secondary outcomes included recurrence at day 60, catheter survival and adverse events.

Eighty-four patients were randomised (42 per arm). Coagulase-negative Staphylococcus was the most common pathogen (34.5%). Early catheter salvage was higher with ELT (78.6% versus 57.1%; P = .035). Recurrence was lower with ELT at day 60 (20.5% versus 53.7%; P = .002). The median catheter survival was longer (15 versus 8 days), although not statistically significant (P = .283). Fever resolution by day 7 was significantly higher in the ELT group compared with controls (64.3% versus 35.7%; P = .009). Adverse events were infrequent and mild. In multivariate analysis, higher serum albumin was independently associated with an increased likelihood of catheter salvage [odds ratio (OR) 2.43, P = .038], while longer dialysis vintage (OR 0.90, P = .035) and Pseudomonas infection (OR 0.05, P = .014) were associated with reduced salvage rates.

Adjunctive ELT improved early catheter salvage and reduced recurrence without significant adverse effects. These findings support its use as part of salvage protocols in tunnelled catheter infections.

GRAPHICAL ABSTRACT

## Linked entities

- **Chemicals:** ethanol (PubChem CID 702)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, UROD (uroporphyrinogen decarboxylase) [NCBI Gene 7389] {aka PCT, UPD}
- **Diseases:** infective endocarditis (MESH:D004696), Kidney Disease (MESH:D007674), tenderness (MESH:D063806), vein stenosis (MESH:D000071078), fistula (MESH:D005402), Diabetic kidney disease (MESH:D003928), septic shock (MESH:D012772), bloodstream infection (MESH:D018805), AVF (MESH:D001164), MRSA (MESH:D013203), flushing (MESH:D005483), thrombosis (MESH:D013927), chronic glomerulonephritis (MESH:D005921), Pseudomonas infection (MESH:D011552), hypertension (MESH:D006973), CRBSI (MESH:D055499), malnutrition (MESH:D044342), Mortality (MESH:D003643), end-stage renal disease (MESH:D007676), chills (MESH:D023341), Tunnel infection (MESH:D007239), acute kidney injury (MESH:D058186), induration (MESH:D010411), Fever (MESH:D005334), shock (MESH:D012769), alcohol allergy (MESH:D000437), multidrug (MESH:D018088), Klebsiella infections (MESH:D007710), diabetes mellitus (MESH:D003920), chronic kidney disease (MESH:D051436)
- **Chemicals:** glycopeptides (MESH:D006020), heparin (MESH:D006493), beta-lactams (MESH:D047090), ELT (-), cephalosporins (MESH:D002511), fluoroquinolones (MESH:D024841), clindamycin (MESH:D002981), water (MESH:D014867), vancomycin (MESH:D014640), ceftazidime (MESH:D002442), Ethanol (MESH:D000431), methicillin (MESH:D008712), aminoglycosides (MESH:D000617)
- **Species:** Staphylococcus (genus) [taxon 1279], Staphylococcus aureus (species) [taxon 1280], Homo sapiens (human, species) [taxon 9606], Pseudomonas aeruginosa (species) [taxon 287], Klebsiella pneumoniae (species) [taxon 573]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12950961/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12950961/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12950961/full.md

---
Source: https://tomesphere.com/paper/PMC12950961